UCrest Berhad Past Earnings Performance
Past criteria checks 4/6
UCrest Berhad has been growing earnings at an average annual rate of 10.3%, while the Healthcare Services industry saw earnings growing at 14.2% annually. Revenues have been declining at an average rate of 6.4% per year. UCrest Berhad's return on equity is 10.1%, and it has net margins of 24%.
Key information
10.3%
Earnings growth rate
14.6%
EPS growth rate
Healthcare Services Industry Growth | 16.1% |
Revenue growth rate | -6.4% |
Return on equity | 10.1% |
Net Margin | 24.0% |
Last Earnings Update | 31 Aug 2024 |
Recent past performance updates
UCrest Berhad's (KLSE:UCREST) Earnings Are Weaker Than They Seem
Oct 07UCrest Berhad's (KLSE:UCREST) Earnings Aren't As Good As They Appear
Feb 06Recent updates
UCrest Berhad's (KLSE:UCREST) Earnings Are Weaker Than They Seem
Oct 07UCrest Berhad's (KLSE:UCREST) Earnings Aren't As Good As They Appear
Feb 06Returns On Capital At UCrest Berhad (KLSE:UCREST) Have Hit The Brakes
Feb 23Returns On Capital Are Showing Encouraging Signs At UCrest Berhad (KLSE:UCREST)
Oct 13Why UCrest Berhad's (KLSE:UCREST) Earnings Are Weaker Than They Seem
Aug 20We're Not Very Worried About UCrest Berhad's (KLSE:UCREST) Cash Burn Rate
May 17Revenue & Expenses Breakdown
How UCrest Berhad makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Aug 24 | 17 | 4 | 8 | 0 |
31 May 24 | 16 | 5 | 8 | 0 |
29 Feb 24 | 18 | 6 | 7 | 0 |
30 Nov 23 | 17 | 6 | 7 | 0 |
31 Aug 23 | 14 | 2 | 8 | 0 |
31 May 23 | 14 | 0 | 8 | 0 |
28 Feb 23 | 9 | -29 | 21 | 0 |
30 Nov 22 | 5 | -36 | 24 | 0 |
31 Aug 22 | 6 | -36 | 24 | 0 |
31 May 22 | 12 | -35 | 24 | 0 |
28 Feb 22 | 15 | -2 | 14 | 0 |
30 Nov 21 | 29 | 4 | 15 | 0 |
31 Aug 21 | 29 | 10 | 14 | 0 |
31 May 21 | 25 | 12 | 14 | 0 |
28 Feb 21 | 22 | -11 | 14 | 0 |
30 Nov 20 | 9 | -16 | 11 | 0 |
31 Aug 20 | 8 | -20 | 11 | 0 |
31 May 20 | 12 | -21 | 12 | 0 |
29 Feb 20 | 15 | -7 | 11 | 0 |
30 Nov 19 | 20 | -2 | 9 | 0 |
31 Aug 19 | 28 | 1 | 9 | 0 |
31 May 19 | 29 | 6 | 7 | 0 |
28 Feb 19 | 43 | 14 | 6 | 0 |
30 Nov 18 | 48 | 15 | 6 | 0 |
31 Aug 18 | 49 | 17 | 6 | 0 |
31 May 18 | 48 | 15 | 7 | 0 |
28 Feb 18 | 36 | 11 | 4 | 0 |
30 Nov 17 | 25 | 7 | 3 | 0 |
31 Aug 17 | 13 | 3 | 3 | 0 |
31 May 17 | 6 | -1 | 3 | 0 |
31 May 16 | 3 | 1 | 1 | 0 |
31 Dec 15 | 2 | 2 | 2 | 0 |
30 Sep 15 | 2 | -3 | 1 | 0 |
30 Jun 15 | 1 | -3 | 1 | 0 |
31 Mar 15 | 1 | -7 | 2 | 0 |
31 Dec 14 | 1 | -6 | 1 | 0 |
30 Sep 14 | 3 | -1 | 0 | 0 |
30 Jun 14 | 3 | -6 | 1 | 0 |
31 Mar 14 | 3 | -6 | 1 | 0 |
31 Dec 13 | 4 | -6 | 1 | 0 |
Quality Earnings: UCREST has a high level of non-cash earnings.
Growing Profit Margin: UCREST's current net profit margins (24%) are higher than last year (14.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: UCREST has become profitable over the past 5 years, growing earnings by 10.3% per year.
Accelerating Growth: UCREST's earnings growth over the past year (97.8%) exceeds its 5-year average (10.3% per year).
Earnings vs Industry: UCREST earnings growth over the past year (97.8%) exceeded the Healthcare Services industry 20.4%.
Return on Equity
High ROE: UCREST's Return on Equity (10.1%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/23 11:50 |
End of Day Share Price | 2024/12/23 00:00 |
Earnings | 2024/08/31 |
Annual Earnings | 2024/05/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
UCrest Berhad is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|